These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2934070)

  • 1. Lack of effect of propranolol on the steady-state plasma levels of ketanserin.
    Trenk D; Lühr A; Radkow N; Jähnchen E
    Arzneimittelforschung; 1985; 35(8):1286-8. PubMed ID: 2934070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients.
    Hedner T; Pettersson A; Persson B
    J Hypertens Suppl; 1986 Apr; 4(1):S91-3. PubMed ID: 2939221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
    Strano A; Novo S; Raineri A; Alaimo G; Abrignani MG; Cutietta A
    J Hypertens Suppl; 1986 Apr; 4(1):S103-6. PubMed ID: 2939208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of propranolol on the hypotensive action of ketanserin in normotensive rats.
    Malinowska B; Pietraszek M; Chabielska E; Buczko W
    Acta Physiol Pol; 1989; 40(4):356-62. PubMed ID: 2485607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of ketanserin in chronic hemodialysed patients.
    Zazgornik J; Scholz N; Kuska J; Minar E
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):674-6. PubMed ID: 3818146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the antihypertensive effect of propranolol caused by an action within the central nervous system?
    Smits JF; van Essen H; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):221-5. PubMed ID: 7452486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients.
    Edgar B; Collste P; Haglund K; Regårdh CG
    Clin Invest Med; 1987 Sep; 10(5):388-94. PubMed ID: 3677507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure during a combination of ketanserin and hydrochlorothiazide.
    Ferrara LA; Fasano ML; Soro S; Farinaro E; Celentano E; Mancini M
    Int J Clin Pharmacol Res; 1987; 7(6):463-8. PubMed ID: 3440636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketanserin in the treatment of mild hypertension in elderly patients: preliminary results of a controlled double-blind trial.
    Dona G; Ribeiro A; Tammaro AE
    J Hypertens Suppl; 1986 Apr; 4(1):S89-90. PubMed ID: 2939220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA; Tooley M; Sibbald B; Gould SE
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance.
    Fagan TC; Gourley LA; Sawyer PR; Lee JT; Walle T; Gaffney TE
    J Clin Hypertens; 1986 Mar; 2(1):21-9. PubMed ID: 3723158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.
    Williams FM; Leeser JE; Rawlins MD
    Br J Clin Pharmacol; 1986 Sep; 22(3):301-8. PubMed ID: 3768242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing.
    Gielerak G; Kozłowski D; Dłuzniewska E; Roszczyk A; Cholewa M
    Kardiol Pol; 2003 Feb; 58(2):98-108. PubMed ID: 14504635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of ketanserin with atenolol: antihypertensive activity and effect on platelet function.
    Kirch W; Ohnhaus EE
    J Hypertens Suppl; 1986 Apr; 4(1):S67-71. PubMed ID: 2939216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.